{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T17:46:06Z","timestamp":1768585566984,"version":"3.49.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.anndiagpath.2024.152356","type":"journal-article","created":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T17:26:35Z","timestamp":1718731595000},"page":"152356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Evaluation of the diagnostic utility of NCOA3, Maspin and VHL protein expression in pancreatic ductal adenocarcinoma: An immunohistochemical study"],"prefix":"10.1016","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6325-4038","authenticated-orcid":false,"given":"Noha","family":"Elkady","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walaa","family":"Elgendy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed T.","family":"Badr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayam","family":"Aiad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manar","family":"Samara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahla M.","family":"Badr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2024.152356_bb0005","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/437971","article-title":"Cancer incidence in Egypt: results of the national population-based cancer registry program","volume":"2014","author":"Ibrahim","year":"2014","journal-title":"J Cancer Epidemiol"},{"issue":"11","key":"10.1016\/j.anndiagpath.2024.152356_bb0010","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1056\/NEJMra1404198","article-title":"Pancreatic adenocarcinoma","volume":"371","author":"Ryan","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.anndiagpath.2024.152356_bb0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152356_bb0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.anndiagpath.2024.152356_bb0025","doi-asserted-by":"crossref","DOI":"10.1007\/s10689-024-00380-5","article-title":"The role of endoscopic ultrasound in the detection of pancreatic lesions in high-risk individuals","author":"Overbeek","year":"2024","journal-title":"Fam Cancer"},{"issue":"31","key":"10.1016\/j.anndiagpath.2024.152356_bb0030","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.3748\/wjg.v28.i31.4235","article-title":"Early diagnosis of pancreatic cancer: what strategies to avoid a foretold catastrophe","volume":"28","author":"Tonini","year":"2022","journal-title":"World J Gastroenterol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152356_bb0035","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s40644-020-00324-z","article-title":"Mass-forming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation","volume":"20","author":"Schima","year":"2020","journal-title":"Cancer Imaging"},{"issue":"3","key":"10.1016\/j.anndiagpath.2024.152356_bb0040","doi-asserted-by":"crossref","first-page":"382","DOI":"10.5858\/133.3.382","article-title":"Chronic pancreatitis and the differential diagnosis versus pancreatic cancer","volume":"133","author":"Kl\u00f6ppel","year":"2009","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152356_bb0045","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/MPA.0b013e3182546e79","article-title":"How good is endoscopic ultrasound-guided fine-needle aspiration in diagnosing the correct etiology for a solid pancreatic mass?: a meta-analysis and systematic review","volume":"42","author":"Puli","year":"2013","journal-title":"Pancreas"},{"issue":"9","key":"10.1016\/j.anndiagpath.2024.152356_bb0050","article-title":"Diagnostic bioliquid markers for pancreatic cancer: what we have vs","volume":"15","author":"Liou","year":"2023","journal-title":"What We Need Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.anndiagpath.2024.152356_bb0055","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.7150\/thno.47390","article-title":"Upregulation of amplified in breast cancer 1 contributes to pancreatic ductal adenocarcinoma progression and vulnerability to blockage of hedgehog activation","volume":"11","author":"Li","year":"2021","journal-title":"Theranostics"},{"issue":"7","key":"10.1016\/j.anndiagpath.2024.152356_bb0060","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.febslet.2013.01.050","article-title":"Tumor suppressor protein VHL inhibits Hedgehog-Gli activation through suppression of Gli1 nuclear localization","volume":"587","author":"Cho","year":"2013","journal-title":"FEBS Lett"},{"issue":"3","key":"10.1016\/j.anndiagpath.2024.152356_bb0065","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0092-8674(00)80516-4","article-title":"Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P\/CAF and CBP\/p300","volume":"90","author":"Chen","year":"1997","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.anndiagpath.2024.152356_bb0070","doi-asserted-by":"crossref","first-page":"8479","DOI":"10.1073\/pnas.94.16.8479","article-title":"RAC3, a steroid\/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2","volume":"94","author":"Li","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"10.1016\/j.anndiagpath.2024.152356_bb0075","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1038\/onc.2010.90","article-title":"Overexpression of transcriptional coactivator AIB1 promotes hepatocellular carcinoma progression by enhancing cell proliferation and invasiveness","volume":"29","author":"Xu","year":"2010","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.anndiagpath.2024.152356_bb0080","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3892\/ol.2012.803","article-title":"The role of AIB1 in breast cancer","volume":"4","author":"Chang","year":"2012","journal-title":"Oncol Lett"},{"issue":"6","key":"10.1016\/j.anndiagpath.2024.152356_bb0085","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.25549","article-title":"Amplified in breast cancer 1 enhances human cholangiocarcinoma growth and chemoresistance by simultaneous activation of Akt and Nrf2 pathways","volume":"55","author":"Chen","year":"2012","journal-title":"Hepatology"},{"issue":"37","key":"10.1016\/j.anndiagpath.2024.152356_bb0090","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1038\/onc.2014.409","article-title":"NCOA3-mediated upregulation of mucin expression via transcriptional and post-translational changes during the development of pancreatic cancer","volume":"34","author":"Kumar","year":"2015","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.anndiagpath.2024.152356_bb0095","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0002-9440(10)65298-4","article-title":"Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas","volume":"154","author":"Ghadimi","year":"1999","journal-title":"Am J Pathol"},{"issue":"5146","key":"10.1016\/j.anndiagpath.2024.152356_bb0100","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1126\/science.8290962","article-title":"Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells","volume":"263","author":"Zou","year":"1994","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152356_bb0105","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/2001-1326-2-8","article-title":"Role of maspin in cancer","volume":"2","author":"Berardi","year":"2013","journal-title":"Clin Transl Med"},{"issue":"2","key":"10.1016\/j.anndiagpath.2024.152356_bb0110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0304-3835(03)00390-2","article-title":"Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas","volume":"199","author":"Ohike","year":"2003","journal-title":"Cancer Lett"},{"issue":"8","key":"10.1016\/j.anndiagpath.2024.152356_bb0115","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/sj.onc.1207269","article-title":"Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling","volume":"23","author":"Sato","year":"2004","journal-title":"Oncogene"},{"issue":"24","key":"10.1016\/j.anndiagpath.2024.152356_bb0120","doi-asserted-by":"crossref","first-page":"7279","DOI":"10.1158\/1078-0432.CCR-06-1589","article-title":"Maspin: the new frontier","volume":"12","author":"Khalkhali-Ellis","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.anndiagpath.2024.152356_bb0125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2407-10-32","article-title":"Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation","volume":"10","author":"Wu","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.anndiagpath.2024.152356_bb0130","series-title":"Prostate Cancer","article-title":"Maspin expression and its metastasis suppressing function in prostate cancer","author":"Eswar","year":"2016"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152356_bb0135","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3904\/kjim.2004.19.1.15","article-title":"Prognostic significance of maspin in pancreatic ductal adenocarcinoma","volume":"19","author":"Lim","year":"2004","journal-title":"Korean J Intern Med"},{"issue":"5","key":"10.1016\/j.anndiagpath.2024.152356_bb0140","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/modpathol.3800772","article-title":"Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases","volume":"20","author":"Cao","year":"2007","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152356_bb0145","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrc3844","article-title":"VHL, the story of a tumour suppressor gene","volume":"15","author":"Gossage","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"33","key":"10.1016\/j.anndiagpath.2024.152356_bb0150","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.2174\/138161209789649394","article-title":"The VHL tumor suppressor: master regulator of HIF","volume":"15","author":"Haase","year":"2009","journal-title":"Curr Pharm Des"},{"issue":"4","key":"10.1016\/j.anndiagpath.2024.152356_bb0155","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4103\/JOC.JOC_18_17","article-title":"Diagnostic value of S100p, IMP3, Maspin, and pVHL in the differantial diagnosis of pancreatic ductal adenocarcinoma and normal\/chronic pancreatitis in fine needle aspiration biopsy","volume":"35","author":"Aksoy-Altinboga","year":"2018","journal-title":"J Cytol"},{"key":"10.1016\/j.anndiagpath.2024.152356_bb0160","doi-asserted-by":"crossref","first-page":"7215","DOI":"10.2147\/OTT.S211535","article-title":"Downregulation of miR-21 inhibits the malignant phenotype of pancreatic cancer cells by targeting VHL","volume":"12","author":"Sun","year":"2019","journal-title":"Onco Targets Ther"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152356_bb0165","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1186\/s12935-020-01670-5","article-title":"Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma","volume":"20","author":"Zhang","year":"2020","journal-title":"Cancer Cell Int"},{"issue":"5","key":"10.1016\/j.anndiagpath.2024.152356_bb0170","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/scs.0b013e31814b2a36","article-title":"Maspin expression in oral squamous cell carcinoma","volume":"18","author":"Iezzi","year":"2007","journal-title":"J Craniofac Surg"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152356_bb0175","doi-asserted-by":"crossref","first-page":"83","DOI":"10.17511\/ijmrr.2016.i01.013","article-title":"VHL protein expression in renal cell carcinoma","volume":"4","author":"Yadav","year":"2016","journal-title":"Int J Med Res Rev"},{"key":"10.1016\/j.anndiagpath.2024.152356_bb0180","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13000-014-0221-9","article-title":"Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue - a review","volume":"9","author":"Fedchenko","year":"2014","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.anndiagpath.2024.152356_bb0185","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3762651","article-title":"Defining an optimal cut-point value in ROC analysis: an alternative approach","volume":"2017","author":"Unal","year":"2017","journal-title":"Comput Math Methods Med"},{"issue":"6","key":"10.1016\/j.anndiagpath.2024.152356_bb0190","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1158\/1078-0432.CCR-04-1621","article-title":"Association of NCOA3 polymorphisms with breast cancer risk","volume":"11","author":"Burwinkel","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.anndiagpath.2024.152356_bb0195","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41417-022-00449-2","article-title":"NCOA3, a new player in melanoma susceptibility and a therapeutic target","volume":"29","author":"Bezrookove","year":"2022","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152356_bb0200","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12020-021-02819-6","article-title":"NCOA3 is a critical oncogene in thyroid cancer via the modulation of major signaling pathways","volume":"75","author":"Li","year":"2022","journal-title":"Endocrine"},{"issue":"5","key":"10.1016\/j.anndiagpath.2024.152356_bb0205","doi-asserted-by":"crossref","DOI":"10.3892\/or.2023.8542","article-title":"NCoA3 upregulation in breast cancer-associated adipocytes elicits an inflammatory profile","volume":"49","author":"Lira","year":"2023","journal-title":"Oncol Rep"},{"issue":"2","key":"10.1016\/j.anndiagpath.2024.152356_bb0210","doi-asserted-by":"crossref","first-page":"19","DOI":"10.21037\/cco.2019.04.02","article-title":"Inflammation and development of pancreatic ductal adenocarcinoma","volume":"8","author":"Shi","year":"2019","journal-title":"Chin Clin Oncol"},{"issue":"442","key":"10.1016\/j.anndiagpath.2024.152356_bb0215","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.canlet.2018.11.012","article-title":"SRC-3 inhibition blocks tumor growth of pancreatic ductal adenocarcinoma","volume":"1","author":"Song","year":"2019","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152356_bb0220","first-page":"86","article-title":"Expression of the tumor suppressor gene maspin and its significance in intraductal papillary mucinous neoplasms of the pancreas","volume":"7","author":"Kashima","year":"2008","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152356_bb0225","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/01.pai.0000203037.25791.21","article-title":"Maspin is useful in the distinction of pancreatic adenocarcinoma from chronic pancreatitis: a tissue microarray based study","volume":"15","author":"Nash","year":"2007","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2024.152356_bb0230","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.21873\/anticanres.15032","article-title":"Cytoplasmic-only expression of maspin predicts unfavorable prognosis in patients with pancreatic ductal adenocarcinoma","volume":"41","author":"Uchinaka","year":"2021","journal-title":"Anticancer Res"},{"issue":"3","key":"10.1016\/j.anndiagpath.2024.152356_bb0235","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/PAI.0000000000001183","article-title":"The role of Galectin3, Tubulin\u03b2, and Maspin in promoting tumor budding in colorectal carcinoma and their clinical implications","volume":"32","author":"Elkady","year":"2024","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152356_bb0240","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1089\/105072504322783795","article-title":"Maspin expression is directly associated with biological aggressiveness of thyroid carcinoma","volume":"14","author":"Ito","year":"2004","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152356_bb0245","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90887-z","article-title":"Role of cytoplasmic localization of maspin in promoting cell invasion in breast cancer with aggressive phenotype","volume":"11","author":"Sakabe","year":"2021","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.anndiagpath.2024.152356_bb0250","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2017.53","article-title":"SRGN-TGF\u03b22 regulatory loop confers invasion and metastasis in triple-negative breast cancer","volume":"6","author":"Zhang","year":"2017","journal-title":"Oncogenesis"},{"issue":"1","key":"10.1016\/j.anndiagpath.2024.152356_bb0255","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/PAS.0b013e31815701d1","article-title":"Diagnostic utility of S100P and von Hippel-Lindau gene product (pVHL) in pancreatic adenocarcinoma-with implication of their roles in early tumorigenesis","volume":"32","author":"Lin","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2024.152356_bb0260","first-page":"109","article-title":"Expression of von Hippel-Lindau gene product (pVHL) and S100P in cystic neoplasms of the pancreas\u2014with an implication for their roles in tumorigenesis","volume":"42","author":"Liu","year":"2012","journal-title":"Ann Clin Lab Sci"},{"issue":"5","key":"10.1016\/j.anndiagpath.2024.152356_bb0265","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1016\/S0002-9440(10)64799-2","article-title":"Histopathology and molecular genetics of multiple cysts and microcystic (serous) adenomas of the pancreas in von Hippel-Lindau patients","volume":"157","author":"Mohr","year":"2000","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.anndiagpath.2024.152356_bb0270","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1097\/01.MP.0000094088.37888.A6","article-title":"Comparison of epigenetic and genetic alterations in mucinous cystic neoplasm and serous microcystic adenoma of pancreas","volume":"16","author":"Kim","year":"2003","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2024.152356_bb0275","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/1947601910366719","article-title":"The von Hippel-Lindau tumor suppressor protein is destabilized by Src: implications for tumor angiogenesis and progression","volume":"1","author":"Chou","year":"2010","journal-title":"Genes Cancer"},{"issue":"39","key":"10.1016\/j.anndiagpath.2024.152356_bb0280","doi-asserted-by":"crossref","first-page":"14531","DOI":"10.1073\/pnas.0606850103","article-title":"The von Hippel-Lindau tumor suppressor gene product represses oncogenic beta-catenin signaling in renal carcinoma cells","volume":"103","author":"Peruzzi","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"10.1016\/j.anndiagpath.2024.152356_bb0285","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1200\/JCO.2004.05.061","article-title":"Role of VHL gene mutation in human cancer","volume":"22","author":"Kim","year":"2004","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.anndiagpath.2024.152356_bb0290","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nrc2502","article-title":"The von Hippel-Lindau tumour suppressor protein: O2 sensing and cancer","volume":"8","author":"Kaelin","year":"2008","journal-title":"Nat Rev Cancer"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913424000935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913424000935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T06:29:21Z","timestamp":1731652161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913424000935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":58,"alternative-id":["S1092913424000935"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152356","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the diagnostic utility of NCOA3, Maspin and VHL protein expression in pancreatic ductal adenocarcinoma: An immunohistochemical study","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2024.152356","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152356"}}